|
Market Closed -
NYSE
16:00:03 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 119.93 USD | -3.37% |
|
+0.23% | +49.63% |
| 11-06 | Barrington Research Adjusts Haemonetics PT to $145 From $140, Maintains Outperform Rating | MT |
| 11-05 | Haemonetics Corporation, Q2 2027 Earnings Call, Nov 05, 2026 |
| Market Cap | 5.46B 4.89B 4.47B 4.08B 7.69B 513B 7.93B 53.91B 21.5B 274B 20.48B 20.04B 864B | P/E 2027 * |
30.3x | P/E 2028 * | 26.6x |
|---|---|---|---|---|---|
| Enterprise Value | 6.12B 5.49B 5.02B 4.58B 8.63B 575B 8.9B 60.45B 24.1B 307B 22.97B 22.47B 969B | EV / Sales 2027 * |
4.32x | EV / Sales 2028 * | 3.87x |
| Free-Float |
98.74% | Yield 2027 * |
0.83% | Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HAE | Delayed | |
CBOE
| HAE | Real-time | |
|
Tradegate
| HAZ | Real-time | |
|
Deutsche Boerse AG
| HAZ | Delayed | |
|
Börse Stuttgart
| HAZ | Delayed | |
|
Boerse Muenchen
| HAZ | Real-time |
Last Transcript: Haemonetics Corporation
| 1 day | -3.37% | ||
| 1 week | +0.23% | ||
| Current month | +0.23% | ||
| 1 month | +15.85% | ||
| 3 months | +41.06% | ||
| 6 months | +127.70% | ||
| Current year | +49.63% |
| 1 week | 116.79 |  | 132 |
| 1 month | 111.66 | | 132 |
| Current year | 51 | | 132 |
| 1 year | 51 | | 132 |
| 3 years | 47.32 | | 132 |
| 5 years | 43.5 | | 132 |
| 10 years | 36.32 | | 142.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 2016-05-15 | |
James D'Arecca
DFI | Director of Finance/CFO | 55 | 2022-04-10 |
Frank Chan
COO | Chief Operating Officer | 56 | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Kroll
BRD | Director/Board Member | 73 | 2005-12-31 |
| Director/Board Member | 62 | 2016-05-15 | |
Robert Abernathy
BRD | Director/Board Member | 71 | 2017-10-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/24/26 | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 | Free | Director | 2,538 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.37% | +0.23% | +78.71% | +35.58% | 5.65B | |
| -3.23% | +3.51% | -12.02% | +15.72% | 197B | |
| -2.90% | +5.45% | +13.04% | +38.65% | 128B | |
| -2.75% | +11.65% | -7.90% | +17.71% | 128B | |
| +0.96% | +5.15% | -38.02% | +12.24% | 99B | |
| -1.80% | +0.82% | -7.41% | +69.42% | 64.82B | |
| -0.78% | +7.07% | +19.44% | -18.22% | 58.17B | |
| +0.79% | +22.65% | -5.28% | +59.81% | 52.84B | |
| -6.98% | -14.56% | -12.60% | +42.69% | 50.69B | |
| -2.36% | +3.72% | +3.27% | -8.07% | 37.23B | |
| Average | -2.24% | +5.68% | +3.12% | +26.55% | 82.11B | |
| Weighted average by Cap. | -2.25% | +6.08% | -6.29% | +24.59% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.42B 1.27B 1.16B 1.06B 2B 133B 2.06B 14B 5.58B 71.07B 5.32B 5.2B 224B | 1.5B 1.34B 1.23B 1.12B 2.11B 141B 2.17B 14.77B 5.89B 75B 5.61B 5.49B 237B |
| Net income | 177M 159M 145M 133M 250M 16.68B 258M 1.75B 699M 8.9B 666M 652M 28.09B | 207M 186M 170M 155M 292M 19.48B 301M 2.05B 816M 10.39B 778M 761M 32.81B |
| Net Debt | 662M 594M 543M 495M 933M 62.23B 963M 6.54B 2.61B 33.21B 2.48B 2.43B 105B | 327M 293M 268M 245M 461M 30.75B 476M 3.23B 1.29B 16.41B 1.23B 1.2B 51.8B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | US$119.93 | -3.37% | 834,664 |
| 26-11-05 | US$124.11 | -2.60% | 1,302,143 |
| 26-11-04 | US$127.42 | +5.94% | 982,029 |
| 26-11-03 | US$120.28 | +0.12% | 834,602 |
| 26-11-02 | US$120.14 | +0.41% | 678,588 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions
